newborn screening
Status of Newborn Screening Programs in the United States
43
We Need Expanded Newborn Screening
8
Reflections on 50 Years of Newborn Screening
5
Newborn screening in mucopolysaccharidoses
10
Newborn Screening for Duchenne Muscular Dystrophy
7
State Laws Regarding the Retention and Use of Residual Newborn Screening Blood Samples
12
Newborn Screening for Pompe Disease
12
Examination of the Communication Practices Between State Newborn Screening Programs and the Medical Home
9
Newborn Screening Technology: Proceed With Caution
9
Newborn Screening for Biliary Atresia
9
Introduction to the Newborn Screening Fact Sheets
11
Newborn Screening Fact Sheets
32
A Vision of the Future of Newborn Screening
7
Newborn Screening for Cystic Fibrosis in California
13
American Academy of Pediatrics Newborn Screening Task Force Recommendations: How Far Have We Come?
20
Comprehensive Cost-Utility Analysis of Newborn Screening Strategies
11
Parents' Experiences of Expanded Newborn Screening Evaluations
11
Newborn Screening: A Blueprint for the Future Executive Summary: Newborn Screening Task Force Report
5
Preferences for aspects of antenatal and newborn screening: a systematic review
11
Issues in State Newborn Screening Programs
8